Overview

• Blood tests measuring biomarkers like phosphorylated tau can detect Alzheimer's with 90% accuracy.
• These tests outperform traditional methods used by both primary care doctors and specialists.
• Early diagnosis through blood tests can reduce wait times for treatment and clinical trial participation.
• St. Louis-based C2N Diagnostics is a key player in developing these advanced tests.
• Experts anticipate that widespread adoption of blood tests could transform Alzheimer's care and research.